Previous Article | Next Article 
Molecular and Cellular Biology, June 2001, p. 3947-3958, Vol. 21, No. 12
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.12.3947-3958.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
PTEN Expression Causes Feedback Upregulation of
Insulin Receptor Substrate 2
Laura
Simpson,1
Jing
Li,1,
Danny
Liaw,1
Ian
Hennessy,1
Jonathan
Oliner,2,
Fred
Christians,2 and
Ramon
Parsons1,*
Institute of Cancer Genetics, College of
Physicians and Surgeons, Columbia University, New York, New York
10032,1 and Affymetrix, Santa Clara,
California 950512
Received 15 September 2000/Returned for modification 5 December
2000/Accepted 16 March 2001
PTEN is a tumor suppressor that antagonizes phosphatidylinositol-3
kinase (PI3K) by dephosphorylating the D3 position of
phosphatidylinositol (3,4,5)-triphosphate (PtdIns-3,4,5-P3). Given the
importance of PTEN in regulating PtdIns-3,4,5-P3 levels, we used
Affymetrix GeneChip arrays to identify genes regulated by PTEN. PTEN
expression rapidly reduced the activity of Akt, which was followed by a
G1 arrest and eventually apoptosis. The gene encoding
insulin receptor substrate 2 (IRS-2), a mediator of insulin signaling,
was found to be the most induced gene at all time points. A
PI3K-specific inhibitor, LY294002, also upregulated IRS-2, providing
evidence that it was the suppression of the PI3K pathway that was
responsible for the message upregulation. In addition, PTEN, LY294002,
and rapamycin, an inhibitor of mammalian target of rapamycin, caused a
reduction in the molecular weight of IRS-2 and an increase in the
association of IRS-2 with PI3K. Apparently, PTEN inhibits a negative
regulator of IRS-2 to upregulate the IRS-2-PI3K interaction. These
studies suggest that PtdIns-3,4,5-P3 levels regulate the specific
activity and amount of IRS-2 available for insulin signaling.
*
Corresponding author. Mailing address: Institute of
Cancer Genetics, College of Physicians & Surgeons, Columbia University, 1150 St. Nicholas Ave., Russ Berrie Pavilion, Rm. 302, New York, NY
10032. Phone: (212) 304-7385. Fax: (212) 304-5511. E-mail: rep15{at}columbia.edu.

Present address: Tularik, Genomics, Greenlawn, NY
11740.

Present address: Amgen Inc., Thousand Oaks, CA 91320-1799.
Molecular and Cellular Biology, June 2001, p. 3947-3958, Vol. 21, No. 12
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.12.3947-3958.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Szabolcs, M., Keniry, M., Simpson, L., Reid, L. J., Koujak, S., Schiff, S. C., Davidian, G., Licata, S., Gruvberger-Saal, S., Murty, V. V.V.S., Nandula, S., Efstratiadis, A., Kushner, J. A., White, M. F., Parsons, R.
(2009). Irs2 Inactivation Suppresses Tumor Progression in Pten+/- Mice. Am. J. Pathol.
174: 276-286
[Abstract]
[Full Text]
-
Knobloch, J., Schmitz, I., Gotz, K., Schulze-Osthoff, K., Ruther, U.
(2008). Thalidomide Induces Limb Anomalies by PTEN Stabilization, Akt Suppression, and Stimulation of Caspase-Dependent Cell Death. Mol. Cell. Biol.
28: 529-538
[Abstract]
[Full Text]
-
Kim, J.-S., Lee, C., Bonifant, C. L., Ressom, H., Waldman, T.
(2007). Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA. Mol. Cell. Biol.
27: 662-677
[Abstract]
[Full Text]
-
Lin, C.-Y., Gurlo, T., Haataja, L., Hsueh, W. A., Butler, P. C.
(2005). Activation of Peroxisome Proliferator-Activated Receptor-{gamma} by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3'-Kinase-Dependent Pathway. J. Clin. Endocrinol. Metab.
90: 6678-6686
[Abstract]
[Full Text]
-
Kim, B., van Golen, C. M., Feldman, E. L.
(2005). Insulin-Like Growth Factor I Induces Preferential Degradation of Insulin Receptor Substrate-2 through the Phosphatidylinositol 3-Kinase Pathway in Human Neuroblastoma Cells. Endocrinology
146: 5350-5357
[Abstract]
[Full Text]
-
Kushner, J. A., Simpson, L., Wartschow, L. M., Guo, S., Rankin, M. M., Parsons, R., White, M. F.
(2005). Phosphatase and Tensin Homolog Regulation of Islet Growth and Glucose Homeostasis. J. Biol. Chem.
280: 39388-39393
[Abstract]
[Full Text]
-
Cully, M., Shiu, J., Piekorz, R. P., Muller, W. J., Done, S. J., Mak, T. W.
(2005). Transforming Acidic Coiled Coil 1 Promotes Transformation and Mammary Tumorigenesis. Cancer Res.
65: 10363-10370
[Abstract]
[Full Text]
-
Zhang, D., Bar-Eli, M., Meloche, S., Brodt, P.
(2004). Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor: THE PHOSPHATIDYLINOSITOL 3-KINASE/Akt AND Raf/ERK PATHWAYS TRANSMIT OPPOSING SIGNALS. J. Biol. Chem.
279: 19683-19690
[Abstract]
[Full Text]
-
Neid, M., Datta, K., Stephan, S., Khanna, I., Pal, S., Shaw, L., White, M., Mukhopadhyay, D.
(2004). Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells. J. Biol. Chem.
279: 3941-3948
[Abstract]
[Full Text]
-
McMorran, B., Town, L., Costelloe, E., Palmer, J., Engel, J., Hume, D., Wainwright, B.
(2003). Effector ExoU from the Type III Secretion System Is an Important Modulator of Gene Expression in Lung Epithelial Cells in Response to Pseudomonas aeruginosa Infection. Infect. Immun.
71: 6035-6044
[Abstract]
[Full Text]
-
Pirola, L., Bonnafous, S., Johnston, A. M., Chaussade, C., Portis, F., Van Obberghen, E.
(2003). Phosphoinositide 3-Kinase-mediated Reduction of Insulin Receptor Substrate-1/2 Protein Expression via Different Mechanisms Contributes to the Insulin-induced Desensitization of Its Signaling Pathways in L6 Muscle Cells. J. Biol. Chem.
278: 15641-15651
[Abstract]
[Full Text]
-
Bertelli, D. F., Ueno, M., Amaral, M. E. C., Toyama, M. H., Carneiro, E. M., Marangoni, S., Carvalho, C. R. O., Saad, M. J. A., Velloso, L. A., Boschero, A. C.
(2003). Reversal of denervation-induced insulin resistance by SHIP2 protein synthesis blockade. Am. J. Physiol. Endocrinol. Metab.
284: E679-E687
[Abstract]
[Full Text]